Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Eyenovia ( (EYEN) ) has shared an announcement.
On May 30, 2025, Eyenovia, Inc. entered into a Third Amendment to its Loan and Security Agreement with Avenue Capital Management and other lenders. This amendment restricts lenders from exercising a conversion option if it results in owning more than 9.99% of Eyenovia’s common stock, with the possibility to adjust this limit up to 19.99% with prior notice. Additionally, in the event of a fundamental transaction, lenders can receive equivalent securities or cash as if they had exercised the conversion option before the transaction.
The most recent analyst rating on (EYEN) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Eyenovia stock, see the EYEN Stock Forecast page.
Spark’s Take on EYEN Stock
According to Spark, TipRanks’ AI Analyst, EYEN is a Underperform.
Eyenovia’s stock is heavily weighed down by poor financial performance, including significant operational losses and a weak balance sheet. While there is revenue growth, the negative equity and insufficient cash flow generation are critical risks. Technical indicators also point to a bearish trend, and the valuation metrics are unappealing due to a negative P/E ratio and absence of dividends. These factors result in a low overall score.
To see Spark’s full report on EYEN stock, click here.
More about Eyenovia
Average Trading Volume: 1,560,928
Technical Sentiment Signal: Sell
Current Market Cap: $6.08M
For an in-depth examination of EYEN stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue